Raymond Gadowski
Cardiovascular Disease · Livonia, MINPI 1851371793
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $737 and has fallen 98.3% since, to $13 in 2022. That places this record below the midpoint for cardiovascular disease clinicians in MI, where the typical reported total is $2,775.
Across 123 payments — averaging $15.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$433
- Novartis$298
- Amgen$221
- AstraZeneca$148
- Sanofi-aventis U.S. LLC$127
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$85
- plus $542 from 19 others
What the payments were for
- Food & beverage$1,853100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 30 | $433 |
| Novartis | 22 | $298 |
| Amgen | 12 | $221 |
| AstraZeneca | 11 | $148 |
| Sanofi-aventis U.S. LLC | 6 | $127 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $85 |
| Merck | 4 | $67 |
| Boehringer Ingelheim | 3 | $48 |
| Esperion Therapeutics, Inc. | 3 | $46 |
| Amarin Pharma, Inc. | 3 | $41 |
| Pfizer | 2 | $29 |
| Lundbeck LLC | 2 | $27 |
| Medtronic(2 entities) | 2 | $27 |
| Actelion Pharmaceuticals US, Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Edwards Lifesciences | 2 | $27 |
| Boston Scientific | 2 | $27 |
| Bardy Diagnostics, Inc. | 2 | $24 |
| Abbott | 1 | $23 |
| Akcea Therapeutics, Inc. | 1 | $22 |
| Angiodynamics, Inc. | 1 | $21 |
| Bayer | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Tactile Systems Technology Inc | 1 | $13 |
| Daiichi Sankyo Inc. | 1 | $12 |
How this compares
$1,853 in reported general payments places this provider in the 40th percentile of 760 cardiovascular disease providers in Michigan.
Other cardiovascular disease in Livonia
- Marschall RungeAnn Arbor$1.8M
- Jihad MustaphaGrand Rapids$1.6M
- Vallerie McLaughlinAnn Arbor$947K
- Pedro Villablanca SpinettoDetroit$620K
- Stanley ChetcutiAnn Arbor$573K
- David HainesRoyal Oak$492K
- Steven AlmanyTroy$471K
- David StroblLansing$445K
- Herman KadoSouthfield$442K
- Douglas HorstmanshofRoyal Oak$407K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.